Search JIC Articles:
The Official Journal of the International Andreas Gruentzig Society
Saturday, July 19, 2008


text size: A A A
manuscripts: submit | review
Treatment of Stent-Jailed Side Branch Stenoses with Rotational Atherectomy
ORIGINAL ARTICLES:
Treatment of Stent-Jailed Side Branch Stenoses with Rotational Atherectomy

- *Robert T. Sperling, MD, Kalon Ho, MD, §David James, MD, Roger Laham, MD, Michael Gibson, MD, Joseph Carrozza, MD

ABSTRACT: While debulking with rotational atherectomy (RA) prior to balloon angioplasty (BA) improves acute results by reducing elastic recoil, treatment of an ostial side branch lesion that is covered (“jailed”) by a stent represents a particular challenge. We report our experience with RA in conjunction with BA for the treatment of ostial stenosis in jailed side branches. Methods and Results. Thirty-two lesions in side branches jailed by a stent were treated with RA and BA 39 times in 30 patients. The mean age was 65.5 ± 11.5 years; 26.3% were women; 18.4% had diabetes mellitus; and 18.4% had a history of prior bypass surgery. Of the treated side branches, 53.9% were diagonals, 71.8% were jailed by a slotted-tube stent, and 86.5% were previously dilated prior to RA. The burr sizes used to treat the jailed side branch origin ranged from 1.25 to 2.25 mm, with a mean burr size of 1.62 ± 0.31 mm. An average of 1.53 ± 0.72 burrs were used per lesion. Quantitative coronary angiography was performed prior to, and after, intervention. The mean diameter stenosis of the side branch prior to revascularization was 77.8% ± 12.6%; this was reduced to a mean stenosis of 23.0% ± 17.9% following treatment with RA and BA. Angiographic success (residual stenosis < 50% and TIMI 3 flow) in the side branch occurred in 36 of 39 lesions (92.3%). Procedural success (angiographic success in both the side branch and the parent vessel in the absence of death, emergent CABG, urgent TVR, and myocardial infarction (CK-MB >/= 3 times normal) during the index hospitalization) was achieved in 33 of 38 cases (86.8%). One patient suffered a periprocedural myocardial infarction; another patient presented with stent thrombosis in the parent vessel requiring emergency revascularization 36 hours after the index procedure. Clinically-driven revascularization of either the side branch or the side branch or parent was performed in 44.8% and 46.4% of patients, respectively. The estimated freedom from any target lesion revascularization was 47.7% at 300 days. One patient died of unknown causes 253 days following the index procedure. Conclusions. RA in conjunction with BA can effectively treat stent-jailed ostial side branch stenosis with excellent acute angiographic and procedural results. However, the long-term efficacy is limited by a high rate of repeat revascularization.



       Percutaneous intervention of coronary ostial stenoses carries a lower procedural success rate and a higher likelihood of acute complication and need for repeat revascularization. Technical challenges related to the treatment of ostial side branches include smaller vessel size, an angulated orientation of the side branch relative to the parent vessel, vascular recoil and plaque shifting into the parent vessel in response to balloon angioplasty. Stents that have been placed in the parent vessel across the origin of side branches confer an additional level of complexity to percutaneous treatment of the side branch. The metal struts of the stent may impede guidewire or balloon access to the “jailed” side branch, and also may limit effective balloon expansion within the side branch. In addition, potential complications of balloon dilatation of side branches through stent struts include device entrapment as well as deformation of the stent struts in the parent vessel.
       Rotational atherectomy is an effective method for debulking plaque, thereby reducing recoil and plaque shift at the origin of side branches. Several case reports from our institution and others have documented the safe and successful use of rotational atherectomy to treat stenoses at the origins of jailed side branches.1–6 We hypothesized that rotational atherectomy is a safe and effective approach to treating stent-jailed ostial side branch disease, with acceptable acute- and long-term outcomes. To investigate this hypothesis, we analyzed the in-hospital and intermediate-term outcomes in 30 consecutive, unselected patients who underwent 38 procedures, using rotational atherectomy to treat ostial lesions in stent-jailed side branches.

Methods
       Between September 26, 1996 and August 23, 2001, a total of 30 consecutive, unselected patients who underwent rotational atherectomy for jailed side branch stenosis underwent 38 procedures, including rotational atherectomy to treat 32 distinct ostial lesions in stent-jailed side branches 39 times (1 patient had 2 distinct stent-jailed ostial lesions treated with rotational atherectomy during a single procedure; 1 patient had 2 distinct stent-jailed ostial lesions treated with rotational atherectomy during 2 separate procedures; 7 distinct lesions underwent repeat revascularization with rotational atherectomy). Rotational atherectomy was performed in the side branch and frequently in the parent vessel using a “stepped burr” approach over a rotational atherectomy guidewire (RotaWire™ Floppy or RotaWire™ Extra Support, Boston Scientific Corp., Natick, Massachusetts). Following debulking with rotational atherectomy, adjunctive balloon angioplasty was performed on all lesions. Frequent revascularization of the parent vessel was also performed with the use of the simultaneous balloon inflations in the parent and side branch vessels (i.e., “kissing balloon” technique) in the majority of cases. Intracoronary brachytherapy with radiation was used in 4 treatments (3 with beta and 1 with gamma radiation). Rotational atherectomy was not performed in the setting of acutely stent-jailed side branch stenosis.
       Quantitative coronary analysis (QCA) was performed prior to and after intervention at the Perfuse Core Laboratory (Boston, Massachusetts) using a previously-described and validated automated edge detection algorithm,7 with the contrast-filled catheter as a reference. A selection was made of the single-plane projection that most clearly identified the stenosis in its greatest severity with minimal foreshortening or overlapping of branches. The interpolated diameters of the normal segment proximal and distal to the traced area of stenosis in the parent vessel was used to determine the parent reference diameter, and the diameter of the normal segment distal to the traced area of stenosis in the side branch was defined as the side branch reference diameter. Lesion length in the side branch was defined as the distance from the proximal edge of the lesion, which was always at the ostium, to the distal shoulder of the lesion. Angiographic success was analyzed on a per-lesion basis, and was defined as < 50% residual stenosis at the target lesion and the presence of TIMI 3 flow at the end of the procedure. Procedural success was analyzed on a per-procedure basis and was defined as angiographic success in both the side branch and the parent vessels and freedom from death, myocardial infarction and urgent target vessel revascularization during the index hospitalization. Serial cardiac enzymes were measured prospectively in all patients. Myocardial infarction was defined as an increase in any post-procedure CK-MB level >/= 3 times normal (30 ng/ml).
       Intermediate clinical follow up was obtained via telephone interview and review of the medical record to ascertain each patient’s vital status and the need for repeat revascularization by percutaneous intervention or coronary artery bypass graft surgery. Intermediate follow up was analyzed on a per-lesion basis, except for death, which was analyzed on a per-patient basis. The decision to perform follow-up angiography was clinically driven. Restenosis was defined as >/= 50% stenosis at the site of the previously treated lesion more than 30 days following the index procedure.
       Continuous data are presented as mean ± standard deviation unless otherwise indicated, and were compared using the unpaired Student’s t-test. The Kaplan-Meier method was performed on a per-lesion basis and was used to estimate freedom from any TLR for side branch and parent vessel lesions that had been initially treated with angiographic success. A p-value £ 0.05 was considered statistically significant.

Results
       Patient and baseline lesion characteristics. Patient demographics are shown in Table 1. Of note, the majority of patients had multivessel disease, 18.4% had diabetes mellitus, and almost 20% had a history of prior coronary artery bypass graft surgery (Table 1). The majority of the treated side branches were diagonal branches (Table 2). More than 70% of stents in the parent vessel were slotted-tube designs. As is our standard practice when treating stent-jailed side branches with rotational atherectomy, the stent struts covering the side branch origin were dilated prior to the index procedure in over 85% of cases to facilitate burr passage and to reduce the risk of burr entrapment.
       Procedural characteristics. An average of 1.53 ± 0.72 burrs were used to treat each side branch lesion, with a mean burr size of 1.62 ± 0.31 mm and a size range of 1.25 mm to 2.25 mm (Table 3). The mean maximum burr-to-artery ratio was 0.79 ± 0.12, using the nominal burr size and the maximum reference diameter of the side branch by QCA. Adjunctive PTCA was performed in all 39 lesions, with a mean maximum balloon pressure of 9.15 ± 3.05 atm (range 4 to 16 atm). The mean maximum balloon-to-artery ratio was 1.26 ± 0.18, using the nominal balloon size and the maximum reference diameter of the branch by QCA. Revascularization of the parent vessel, which required positioning the guidewire in the distal parent vessel, occurred in two-thirds of cases; this was usually due to a lesion in the parent limb just distal to the side branch origin. The kissing balloon technique was used in more than 50% of cases. Intracoronary brachytherapy was administered in 4 of 39 treatments (3 beta, 1 gamma).
Figure 1a
       Acute angiographic results and periprocedural outcomes. The mean reference vessel diameter of the side branch was 1.99 ± 0.36 mm, and did not change significantly following treatment with rotational atherectomy or PTCA (Figure 1A). The minimum luminal diameter (MLD) of the side branch increased significantly from 0.43 ± 0.25 mm to 1.21 ± 0.34 mm following rotational atherectomy (p < 0.001), and increased further to 1.53 ± 0.46 mm after adjunctive PTCA (p < 0.001; post-rotational
Figure 1b
atherectomy compared with post-PTCA) (Figure 1B). This translated to an improvement in stenosis from 77.8% ± 12.6% to 39.1% ± 12.8% after rotational atherectomy to a final residual stenosis of 23.0% ± 17.9% after adjunctive PTCA (p < 0.001; baseline compared with post-rotational atherectomy and post-PTCA) (Figure 1D).
Figure 1c
       Angiographic success in the side branch alone was achieved in 36 of 39 (92.3%) lesions, while angiographic success in both the side branch and the parent vessel was accomplished in 34 of 39 (87.2%) cases (Table 4). Procedural success occurred in 33 of 38 (86.8%) cases. Device failure due to an inability of a burr to successfully cross a stent strut occurred in 1 case (2.6%). This lesion was treated successfully with balloon angioplasty alone. Of note, the lesion had previously been treated at an outside institution, and it was not known whether the side branch had previously been dilated. In 1 patient (2.6%), a
Figure 1d
burr became transiently entrapped in a side branch, resulting in acute closure of the side branch and the only in-hospital myocardial infarction (peak CK-MB of 75 ng/ml). In this case, the stent strut had previously been dilated during the procedure prior to rotational atherectomy. There were no deaths or urgent TVR procedures during the index hospitalization. One other periprocedural complication occurred in a patient who presented with subacute thrombosis of the parent vessel proximal to the side branch 36 hours following the index procedure, which led to a nonfatal Q-wave myocardial infarction.
Tables 1-3
       Intermediate clinical follow up. Follow up was obtained for all patients after each procedure for a median of 664 days and a range of 1 to 1,700 days. Clinically-driven follow-up angiography was performed 19 times following 28 index procedures (19/28 = 67.9%) that achieved angiographic success in both the side branch and parent vessels. Angiographic restenosis occurred in either the side branch or the parent vessel in 13 cases (Table 5). Of the 29 side branches that initially underwent
Tables 4 and 5
angiographically successful procedures, clinically-driven repeat revascularization was performed in 13 cases (13/29 = 44.8%). However, 2 of these cases had follow-up diameter stenoses of 27% and 33%, and at least 1 of these cases of mild restenosis underwent repeat revascularization after plaque shift into the side branch **Sperling3.jpg**during treatment of significant parent vessel restenosis. Of the 32 index side branch lesions in which both the side branch and the parent vessel were successfully treated, clinically-driven repeat revascularization of either the side branch or the parent vessel was performed in 13 cases (13/28 = 46.4%). The estimated freedom from any TLR was 47.7% at 300 days (Figure 2). There was 1 death of unknown etiology which occurred 253 days following the index procedure.

Discussion
       PTCA of stenoses at the origin of side branches generally has a lower procedural success rate and a higher incidence of complications compared with PTCA of non-ostial lesions.8,9 Rotational atherectomy, which relies on plaque abrasion and pulverization to reduce elastic recoil and plaque shifting, has been used with a high procedural success rate for aorto-ostial and branch-ostial stenoses.10–12 Coronary ostial side branch stenoses jailed by parent vessel stents represent a particular technical challenge for percutaneous revascularization. Although balloon angioplasty has been used to reopen jailed side branches, procedural success was achieved in only 84% of cases, with a mean residual diameter stenosis of 28 ± 6%.13 While several case reports have described the successful use of rotational atherectomy to treat stent-jailed ostial side branch stenoses, long-term clinical outcome is unknown.1–6
       In this study we reviewed a consecutive, unselected series of 30 patients undergoing 38 procedures involving treatment of 32 stent-jailed ostial side branch lesions treated 39 times. Angiographic success was achieved in 92% of treated side branches, which compares favorably with previous studies of balloon angioplasty to treat ostial side branch stenoses, with reported angiographic success rates ranging from 74% to 87%.9,14 In addition, we found an acceptable rate of procedural complications, including a 2.6% rate of periprocedural myocardial infarction, 1 case of stent thrombosis of the parent vessel proximal to the side branch and no cases of emergent CABG surgery or death.
       Despite the high procedural success rate, repeat revascularization was common in our study. The TVR rate of 44.8% undoubtedly reflects the unfavorable impact of variables such small vessel size, ostial location and high incidence of previous revascularization of the treated side branches. Also, of the 13 cases of side branch TVR, 2 had mild restenosis (27% and 33%), and at least 1 underwent repeat revascularization due to plaque shift during treatment of the parent vessel. These cases of “innocent bystander” repeat revascularization increase the overall rate of repeat revascularization than might be anticipated following revascularization of isolated jailed side branch restenosis without parent vessel involvement.
       An important technical consideration when using rotational atherectomy to treat side branches covered by stents is the importance of ensuring that the side branch has been previously dilated through the side of the stent. This may facilitate passage of the burr and may reduce the potential complication of burr entrapment. Another potential concern is the liberation of metallic particles during rotablation of the stent strut. However, there were no cases of periprocedural myocardial infarction following angiographically successful revascularization of side branches with rotational atherectomy in our series, suggesting that rotational atherectomy through the sides of stents can be performed safely.
       Study limitations. Limitations of our report include the retrospective design of the study. Also, the comparison of rotational atherectomy with other modalities of revascularization, including plain-old balloon angioplasty or bifurcation stenting for the treatment of stent-jailed ostial side branch stenosis is precluded by the lack of a randomized control design. Furthermore, these were highly selected, rather than random, cases based on angiographic appearance; not every patient who had a stent-jailed side branch stenosis underwent treatment with rotational atherectomy. Another limitation is that some patients who received rotational atherectomy underwent adjunctive treatment with brachytherapy. Although brachytherapy should not affect the acute result, brachytherapy could affect the long-term outcome. However, the total number of stent-jailed side branch stenoses that received adjunctive brachytherapy is a small percentage of the total number of treatments (10%).
       Our study is the first reported series of cases using rotational atherectomy to treat stent-jailed ostial side branch disease. Although we found that acutely, rotational atherectomy is a safe and effective approach, these data do not support the notion that rotational atherectomy is a superior technique compared with balloon angioplasty to treat stent-jailed side branch stenoses. In addition, restenosis remains a formidable clinical problem due in part to the location and size of the target vessels. Further studies are required to determine the optimal modality of therapy and the potential roles of newer interventional technologies, such as brachytherapy and drug-eluting stents, in treating these challenging lesions.


1. Abdelmeguid AE. New technique for stent jail: Another niche for the Rotablator. Cathet Cardiovasc Diagn 1997;42:321–324.
2. Duvvuri S, Daley-Sterling F, Sharma SK, Ambrose JA. Rotational atherectomy of a side branch through a Palmaz-Schatz stent: Is stent jail impenetrable to rotational atherectomy? J Invasive Cardiol 1998;10:187–190.
3. Dauerman HL, Cohen DJ, Carrozza JPJ, et al. Rotational atherectomy for the treatment of restenotic ostial side branches jailed by prior stent placement. Cathet Cardiovasc Diagn 1998;43:447–450.
4. Hammond C, Morris JL, Perry R. Rotational atherectomy of a restenotic lesion through the wall of a stent — Getting out of stent jail. J Invasive Cardiol 1998;10:401–404.
5. Mushahwar SS, Ramsdale DR. Escape from true stent jail by use of the Rotablator. J Invasive Cardiol 2000;12:99–101.
6. Kini A, Vidhun R, Sharma S. Rotational atherectomy: A new treatment modality for ostial stenoses of "stent-jailed" side branches. J Invasive Cardiol 1998;10:169–172.
7. Gibson CM, Sandor T, Stone PH, et al. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol 1992;69:1286–1290.
8. Mathias DW, Mooney JF, Lange HW, et al. Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol 1991;67:491–495.
9. Tan KH, Sulke N, Taub N, Sowton E. Percutaneous transluminal coronary angioplasty of aorta ostial, non-aorta ostial, and branch ostial stenoses: Acute and long-term outcome. Eur Heart J 1995;16:631–639.
10. Zimarino M, Corcos T, Favereau X, et al. Rotational coronary atherectomy with adjunctive balloon angioplasty for the treatment of ostial lesions. Cathet Cardiovasc Diagn 1994;33:22–27.
11. Koller PT, Freed M, Grines CL, O'Neill WW. Success, complications, and restenosis following rotational and transluminal extraction atherectomy of ostial stenoses. Cathet Cardiovasc Diagn 1994;31:255–260.
12. Popma JJ, Brogan WC, Pichard AD, et al. Rotational coronary atherectomy of ostial stenoses. Am J Cardiol 1993;71:436–438.
13. Caputo RP, Chafizadeh ER, Stoler RC, et al. Stent jail: A minimum-security prison. Am J Cardiol 1996;77:1226–1229.
14. Mathias DW, Mooney JF, Lange HW, et al. Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol 1991;67:491–495.

The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 18 - Issue 8 - August 2006 - Pages: 354 - 358



CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE

On Demand Web Archive
Non-Accredited


This activity is supported by an educational grant from Terumo Medical Corporation.
Pharmacoinvasive Management of Acute Coronary Syndrome: Incorporating the 2007 ACC/AHA Guidelines

Complimentary Accredited CME Program

This activity is supported by an educational grant from Sanofi-Aventis.
Varicose Veins: Causes, Symptoms, Diagnosis and Treatment of Chronic Venous Insufficiency

A Complimentary Accredited ON-DEMAND Webcast

This activity is supported by an educational grant from Diomed, Inc.


Create a Successful Vena Cava Filter Practice

Accredited CD

This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.

Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast

Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.

Anticoagulation Techniques for Peripheral Vascular Interventions

Complimentary Accredited ON DEMAND Webcast

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.


March 2007 Supplement
On-Demand Webcast
Archived Webcast
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285